These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

976 related items for PubMed ID: 27036111

  • 1. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
    Madan A, Mijovic-Das S, Stankovic A, Teehan G, Milward AS, Khastgir A.
    BMC Nephrol; 2016 Mar 31; 17():37. PubMed ID: 27036111
    [Abstract] [Full Text] [Related]

  • 2. Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel.
    Bomback AS, Tumlin JA, Baranski J, Bourdeau JE, Besarab A, Appel AS, Radhakrishnan J, Appel GB.
    Drug Des Devel Ther; 2011 Mar 14; 5():147-53. PubMed ID: 21448451
    [Abstract] [Full Text] [Related]

  • 3. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial.
    Bomback AS, Canetta PA, Beck LH, Ayalon R, Radhakrishnan J, Appel GB.
    Am J Nephrol; 2012 Mar 14; 36(1):58-67. PubMed ID: 22722778
    [Abstract] [Full Text] [Related]

  • 4. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
    Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, D'Amico G.
    Am J Kidney Dis; 1997 Sep 14; 30(3):404-12. PubMed ID: 9292570
    [Abstract] [Full Text] [Related]

  • 5. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Yokoyama H, Sugiyama H, Narita I, Saito T, Yamagata K, Nishio S, Fujimoto S, Mori N, Yuzawa Y, Okuda S, Maruyama S, Sato H, Ueda Y, Makino H, Matsuo S.
    Clin Exp Nephrol; 2015 Jun 14; 19(3):496-505. PubMed ID: 25230687
    [Abstract] [Full Text] [Related]

  • 6. Glomerulonephritis Histopathological Pattern Change.
    AlYousef A, AlSahow A, AlHelal B, Alqallaf A, Abdallah E, Abdellatif M, Nawar H, Elmahalawy R.
    BMC Nephrol; 2020 May 18; 21(1):186. PubMed ID: 32423387
    [Abstract] [Full Text] [Related]

  • 7. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
    Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, D'Amico G.
    Nephrol Dial Transplant; 2002 Nov 18; 17(11):1890-6. PubMed ID: 12401843
    [Abstract] [Full Text] [Related]

  • 8. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
    Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Terada Y, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.
    Clin Exp Nephrol; 2020 Jun 18; 24(6):526-540. PubMed ID: 32146646
    [Abstract] [Full Text] [Related]

  • 9. A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathy.
    Hladunewich MA, Cattran D, Beck LH, Odutayo A, Sethi S, Ayalon R, Leung N, Reich H, Fervenza FC.
    Nephrol Dial Transplant; 2014 Aug 18; 29(8):1570-7. PubMed ID: 24714414
    [Abstract] [Full Text] [Related]

  • 10. Consequences of insurance denials among U.S. patients prescribed repository corticotropin injection (Acthar Gel) for nephrotic syndrome.
    Rice JB, Panaccio MP, White A, Simes M, Billmyer E, Downes N, Niewoehner J, Wan GJ.
    Curr Med Res Opin; 2021 Mar 18; 37(3):431-441. PubMed ID: 33411573
    [Abstract] [Full Text] [Related]

  • 11. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
    Am J Kidney Dis; 2009 Jul 18; 54(1):51-8. PubMed ID: 19406543
    [Abstract] [Full Text] [Related]

  • 12. Rationale and design of the Japanese Biomarkers in Nephrotic Syndrome (J-MARINE) study.
    Kurasawa S, Kato S, Ozeki T, Akiyama S, Ishimoto T, Mizuno M, Tsuboi N, Kato N, Kosugi T, Maruyama S, J-MARINE collaborators.
    Clin Exp Nephrol; 2024 May 18; 28(5):431-439. PubMed ID: 38267800
    [Abstract] [Full Text] [Related]

  • 13. [Tubular lesions in the nephrotic syndrome].
    Robeva R, Lagrue J.
    Vutr Boles; 1989 May 18; 28(6):43-8. PubMed ID: 2576694
    [Abstract] [Full Text] [Related]

  • 14. ACTH Treatment for Management of Nephrotic Syndrome: A Systematic Review and Reappraisal.
    Chakraborty R, Mehta A, Nair N, Nemer L, Jain R, Joshi H, Raina R.
    Int J Nephrol; 2020 May 18; 2020():2597079. PubMed ID: 32566293
    [Abstract] [Full Text] [Related]

  • 15. Is there really an increase in non-minimal change nephrotic syndrome in children?
    Filler G, Young E, Geier P, Carpenter B, Drukker A, Feber J.
    Am J Kidney Dis; 2003 Dec 18; 42(6):1107-13. PubMed ID: 14655180
    [Abstract] [Full Text] [Related]

  • 16. Pharmacologic management of adult idiopathic nephrotic syndrome.
    Alaniz C, Brosius FC, Palmieri J.
    Clin Pharm; 1993 Jun 18; 12(6):429-39. PubMed ID: 8403814
    [Abstract] [Full Text] [Related]

  • 17. A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome.
    Bazzi C, Petrini C, Rizza V, Arrigo G, D'Amico G.
    Kidney Int; 2000 Oct 18; 58(4):1732-41. PubMed ID: 11012907
    [Abstract] [Full Text] [Related]

  • 18. Spectrum of glomerulonephritides in adults with nephrotic syndrome in Pakistan.
    Kazi JI, Mubarak M, Ahmed E, Akhter F, Naqvi SA, Rizvi SA.
    Clin Exp Nephrol; 2009 Feb 18; 13(1):38-43. PubMed ID: 18685922
    [Abstract] [Full Text] [Related]

  • 19. Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.
    Hogan J, Bomback AS, Mehta K, Canetta PA, Rao MK, Appel GB, Radhakrishnan J, Lafayette RA.
    Clin J Am Soc Nephrol; 2013 Dec 18; 8(12):2072-81. PubMed ID: 24009220
    [Abstract] [Full Text] [Related]

  • 20. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D'Agati VD.
    Kidney Int; 2003 Oct 18; 64(4):1232-40. PubMed ID: 12969141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.